Navigation Links
Beckman Coulter Announces Third Quarter 2009 Results
Date:10/29/2009

o recurring revenue. Clinical Diagnostics experienced strong growth in recurring revenue especially in Access Immunoassay, which again grew more than 10%. Recurring revenue growth attests to the ongoing strength of our business model even in a difficult economic environment."

A decline in cash instrument sales partially offset strong recurring revenue growth. Chemistry and Clinical Automation cash instrument sales were 7.3% higher due to $8.5 million of revenue from ODS. All other product areas experienced declines in cash instrument sales due to weakness in all major markets except China. A weak capital expenditure environment and difficult prior year comparisons contributed to these results.

In the quarter, Clinical Diagnostics revenues increased 4.7% in constant currency, excluding ODS. Life Science revenue declined 9%, or 6.8% in constant currency.

On a geographic basis, third quarter revenue in the U.S. increased 6.8%, with the ODS acquisition contributing 5.6%. In constant currency, international revenue grew 16.2%; ODS contributed 11.5% to this growth. International growth was driven by continued strength in Asia Pacific, in Europe as a result of the ODS acquisition and by substantial gains in Immunoassay.

Growth in higher margin recurring revenue more than offset the unfavorable effect of currency and an increase in pension expense. As a result, third quarter adjusted gross profit margin increased 120 basis points to 47.2% versus prior year results.

Third quarter operating income was $4.4 million. On an adjusted basis, operating income for the quarter was $103.7 million, 12.6% of revenue, or 13.5% excluding the ODS acquisition.

Non-operating expense of $4.9 million includes a net gain realized in the period related to the Yen hedge for the ODS acquisition. Adjusted non-operating expense includes incremental interest expense incurred on the debt offering associated with the
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
2. Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers
3. Beckman Coulter to Present at Upcoming Healthcare Conferences
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... -- MEI Pharma, Inc. (Nasdaq: MEIP ), an oncology company ... announced today that Daniel P. Gold , Ph.D., President ... America Merrill Lynch 2015 Health Care Conference on Wednesday, May ... at the Wynn in Las Vegas . ... www.meipharma.com . A replay will be available approximately one ...
(Date:5/6/2015)... 6, 2015 - Annual List ... Technology Solution Providers 2015 - Indegene Makes ... Life Sciences Technology Solution Providers for its Clinical, Commercial, ... Organizations CIO Review (cioreview.com) has chosen Indegene ... Sciences Technology Solution Providers 2015. The positioning is based ...
(Date:5/6/2015)... , May 6, 2015 Adaptive Biotechnologies, ... (NGS) of T-cell and B-cell receptors in the ... Series F financing round with a $195 million ... round was led by Matrix Capital Management and ... Management, Rock Springs Capital and an additional large ...
Breaking Medicine Technology:MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference 2CIO Review Selects Indegene for 20 Most Promising Pharma and Life Sciences Technology Solution Providers 2015 2Adaptive Biotechnologies Enhances Leading Position in Growing Immunosequencing Market with Completion of $195 Million Investment 2
... Mylan Inc. (Nasdaq: MYL ) today ... final approval from the U.S. Food and Drug Administration ... Nabumetone Tablets USP, 500 mg and 750 mg. The ... equivalent to Nabumetone Tablets, a treatment for osteoarthritis and ...
... and TULSA, Okla. , July 14 ... prescribing strategic alliance to increase the availability of important ... Tamoxitest™. These tests and the GeneMedRx medication management software ... to personalize their prescribing practices in order to prevent ...
Cached Medicine Technology:Mylan Receives Approval for Nabumetone Tablets 2Helix Bioscience Appointed DNA Drug Sensitivity Testing Distributor for Genelex Corporation 2
(Date:5/6/2015)... May 06, 2015 As Hilo ... HIMSS EMR Adoption Model, the hospital looked for ... engagement and automate processes. The leadership team realized ... to electronic workflows, patient registration still required patients ... consents. With HIMSS Stage 7 attestation fast approaching, ...
(Date:5/6/2015)... A quality built chicken coop condo with a ... way to raise chickens on a pasture. By installing a ... will have a chicken tractor that stands up to being moved ... as it is able to flex to uneven ground without losing ... land are fertilized, and it will help provide the chickens with ...
(Date:5/6/2015)... BC (PRWEB) May 06, 2015 Experienced ... Care, has recently announced that they will now conduct ... for strata complexes in addition to commercial and residential ... scale and require a lot of technical knowledge as ... we do an installation we will take away any ...
(Date:5/6/2015)... May 06, 2015 Chesapeake Regional ... state of Virginia to acquire Intuitive Surgical, Inc.’s ... The system upgrade includes enhanced surgical technique capabilities, ... procedures across a wide spectrum of specialties. Its ... pain and quicker recovery times. , “As the ...
(Date:5/6/2015)... May 06, 2015 Prime Pacific ... is excited to announce a new series of ... the industry’s carbon footprint while improving treatment efficacy ... Eco-Flex™, the world’s first waste hose ... game-changer for hydrotherapists,” claims the company’s president, Mr. ...
Breaking Medicine News(10 mins):Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Chicken Coop Condo Launches the Chicken Tractor 2Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3
... By Jenifer Goodwin HealthDay Reporter , TUESDAY, ... of heart attack rise by about 10 percent for every ... an ambulance and the time that patient is treated in ... Denmark analyzed data from Danish medical registries on 6,209 patients ...
... discovered an accomplice in breast cancer a master control ... reactions orchestrated by a cancer-causing gene (or oncogene) named Wnt1. ... back-to-back papers featured on the cover of the August 15 ... about the regulation of a Wnt oncogene," explains lead author ...
... Reporter , TUESDAY, Aug. 17 (HealthDay News) -- Less invasive biopsies ... make up the majority of biopsies being done, a new study ... increased from 59 percent to 67 percent of all biopsies between ... expert noted. A biopsy involves the removal of tissue or fluids ...
... treat drug-resistant staph infections, but most follow national guideline ... at Chicago. Researchers sent a 61-item questionnaire to ... to learn of their policies and practices regarding methicillin-resistant ... hospitals are members of Broadlane, a health care cost ...
... , This release is available in Spanish ... brain. But much remains to be discovered about the relation ... Department of Agriculture (USDA) nutritionist Lindsay H. Allen has collaborated ... the role these nutrients may play in preventing decline in ...
... French . , Montreal, August 17, 2010 ... likely to befriend deviant peers and become heavy drug users ... journal Addictive Behaviors . Yet the investigation by scientists ... Center found that bad boys can be protected from heavy ...
Cached Medicine News:Health News:Deaths From Heart Attack Rise With Delays in Care 2Health News:Deaths From Heart Attack Rise With Delays in Care 3Health News:Researchers identify breast cancer culprits 2Health News:Less Invasive Biopsies Gain Favor 2Health News:MRSA policies differ among hospitals, study shows 2Health News:B vitamins and the aging brain examined 2Health News:Heavy drug-use among bad boys curbed by parental monitoring and peers 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: